SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced that it has entered into a non-binding term sheet to sell certain cardiac and peripheral catheter platform assets and technology for $3 million to Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures. The purchase will include the transfer from Micrus to Merit of manufacturing know-how, intellectual property, inventory and technology.
